Sales rise 4.78% to Rs 550.03 crore
Net profit of Anthem Biosciences rose 7.10% to Rs 173.43 crore in the quarter ended September 2025 as against Rs 161.93 crore during the previous quarter ended September 2024. Sales rose 4.78% to Rs 550.03 crore in the quarter ended September 2025 as against Rs 524.96 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 550.03 | 524.96 | 5 |
| OPM % | 39.62 | 37.19 | - |
| PBDT | 263.10 | 219.52 | 20 |
| PBT | 229.60 | 199.53 | 15 |
| NP | 173.43 | 161.93 | 7 |
Powered by Capital Market - Live News